5-Hydroxybenzo[de]isochromene-1,3-dione, 95.0%, 25g

tert-Butyl piperazin-1-ylacetate, 97.0%, 10g

N-(4-chlorobenzyl)-2-propanamine hydrochloride, 95.0%, 5g

(2S)-2-benzyl-N,N-dimethylaziridine-1-sulfonamide, 97%, 250mg

4-(Cyanomethyl)benzamide, 97%, 2.5g

5H-Spiro[furo[3,4-b]pyridine-7,4'-piperidine] dihydrochloride, 97%, 250mg

(R)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-((tert-butoxycarbonyl)amino)propanoate, 98%, 1g

2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indole-1,3-dicarboxylic acid, 95%, 100mg

Methyl 2-amino-4-(trifluoromethyl)thiophene-3-carboxylate, 97%, 1g

2-(9,9'-Spirobi[fluoren]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 99%, 25g

1-BOC-3-(AMINOMETHYL)-3-METHYLAZETIDINE, 95.0%, 25g

Morfolina, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

(S)-3-((tert-Butoxycarbonyl)amino)-4-(m-tolyl)butanoic acid, 98%, 1g